Geode Capital Management’s HCW Biologics HCWB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-5,924
| Closed | -$66.9K | – | 4476 |
|
|
2025
Q1 | $66.9K | Buy |
5,924
+1,375
| +30% | +$15.5K | ﹤0.01% | 4137 |
|
|
2024
Q4 | $81.2K | Sell |
4,549
-32
| -0.7% | -$571 | ﹤0.01% | 4148 |
|
|
2024
Q3 | $98.9K | Buy |
4,581
+321
| +8% | +$6.93K | ﹤0.01% | 4104 |
|
|
2024
Q2 | $110K | Sell |
4,260
-97
| -2% | -$2.51K | ﹤0.01% | 4115 |
|
|
2024
Q1 | $291K | Buy |
4,357
+996
| +30% | +$66.6K | ﹤0.01% | 3805 |
|
|
2023
Q4 | $165K | Buy |
3,361
+48
| +1% | +$2.35K | ﹤0.01% | 4005 |
|
|
2023
Q3 | $253K | Buy |
3,313
+37
| +1% | +$2.83K | ﹤0.01% | 3884 |
|
|
2023
Q2 | $284K | Hold |
3,276
| – | – | ﹤0.01% | 3888 |
|
|
2023
Q1 | $181K | Hold |
3,276
| – | – | ﹤0.01% | 4099 |
|
|
2022
Q4 | $251K | Sell |
3,276
-7
| -0.2% | -$536 | ﹤0.01% | 3970 |
|
|
2022
Q3 | $300K | Buy |
3,283
+1,897
| +137% | +$173K | ﹤0.01% | 3985 |
|
|
2022
Q2 | $121K | Buy |
1,386
+57
| +4% | +$4.98K | ﹤0.01% | 4505 |
|
|
2022
Q1 | $145K | Buy |
1,329
+267
| +25% | +$29.1K | ﹤0.01% | 4517 |
|
|
2021
Q4 | $98K | Buy |
1,062
+528
| +99% | +$48.7K | ﹤0.01% | 4740 |
|
|
2021
Q3 | $68K | Buy |
+534
| New | +$68K | ﹤0.01% | 4743 |
|